CompletedNot Applicable

Glycemic Fluctuations in Newly Diagnosed Growth Hormone-Secreting Pituitary Adenoma and Cushing Syndrome Subjects

China60 participantsStarted 2014-12-01

Plain-language summary

Glucose fluctuations present not only in patients with diabetes mellitus but also in subjects with normal glucose tolerance or impaired glucose regulation. People with Growth Hormone-Secreting Pituitary Adenoma and Cushing Syndrome are at risk of impaired glucose metabolism. Glycemic variability is poorly studied in the nondiabetic individuals. The aim of the study is to investigate the characteristics of glucose fluctuations in the newly diagnosed Growth Hormone-Secreting Pituitary Adenoma and Cushing Syndrome individuals.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * •newly diagnosed GH-releasing pituitary adenoma * •newly diagnosed Cushing Syndrome Exclusion Criteria: * •history of diabetes mellitus and being treated with drugs * •being treated with drugs which affect glucose metabolism in the lately 3 months * •with other hormones affecting glucose metabolism secreted abnormally by pituitary * •serious comorbidity like malignant tumour, severe hepatosis or nephropathy, serious hypertension(blood pressure\> 180/110mmhg) * •pregnant or breastfeeding women * •patients allergic to patches or metal

What they're measuring

Continuous glucose profiles of mean data of 24-hour continuous glucose monitoring by the CGMS Gold

Timeframe: 3 days

Trial details

NCT IDNCT02574793

SponsorHuashan Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2017-12-31

View on ClinicalTrials.gov More Pituitary Adenoma trials